Discrepant thyroid function tests in a patient treated with interferon-alpha.
作者信息
Chan Wing Bun, Chow Chun Chung, Cockram Clive Stewart
机构信息
Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, NT, HKSAR.
出版信息
J R Soc Med. 2002 Oct;95(10):506. doi: 10.1258/jrsm.95.10.506.
Abstract
摘要
相似文献
1
Discrepant thyroid function tests in a patient treated with interferon-alpha.接受α-干扰素治疗患者的甲状腺功能检查结果异常。
J R Soc Med. 2002 Oct;95(10):506. doi: 10.1258/jrsm.95.10.506.
2
Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report.
Endocr J. 1997 Oct;44(5):715-7. doi: 10.1507/endocrj.44.715.
3
Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.α-干扰素治疗慢性粒细胞白血病并发血栓性血小板减少性紫癜。两例成功治疗病例报告。
Acta Haematol. 1998;100(4):204-6. doi: 10.1159/000040905.
4
Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.
Hawaii Med J. 2002 Mar;61(3):48, 57.
5
Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia.
Anticancer Drugs. 2001 Jan;12(1):7-8. doi: 10.1097/00001813-200101000-00002.
6
Interferon-associated retinopathy.干扰素相关性视网膜病变
Eye (Lond). 2003 May;17(4):534-6. doi: 10.1038/sj.eye.6700391.
7
The Raynaud phenomenon and interferon therapy.雷诺现象与干扰素治疗
Ann Intern Med. 1996 Sep 1;125(5):423. doi: 10.7326/0003-4819-125-5-199609010-00025.
8
Renal thrombotic microangiopathy induced by interferon-alpha.α干扰素诱导的肾血栓性微血管病
Nephrol Dial Transplant. 2001 Apr;16(4):846-8. doi: 10.1093/ndt/16.4.846.
9
"Myorhythmia" slow facial tremor from chronic interferon alpha-2a usage.“肌节律异常”：慢性使用α-2a干扰素引起的面部缓慢震颤。
Neurology. 2003 Nov 11;61(9):1302-3. doi: 10.1212/01.wnl.0000090041.02085.22.
10
Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders.
Br J Dermatol. 2002 Aug;147(2):385-6. doi: 10.1046/j.1365-2133.2002.48901.x.
引用本文的文献
1
Triggering of thyroid hormone autoantibodies.甲状腺激素自身抗体的触发
J R Soc Med. 2003 Jan;96(1):50. doi: 10.1258/jrsm.96.1.50.
本文引用的文献
1
Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.α干扰素诱导的甲状腺自身免疫的长期结局及治疗结束时甲状腺自身抗体模式的预后影响
J Clin Endocrinol Metab. 2001 May;86(5):1925-9. doi: 10.1210/jcem.86.5.7459.
2
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.α干扰素治疗慢性丙型肝炎诱导产生针对肾上腺皮质和胰岛细胞的自身抗体。
Gut. 2001 Mar;48(3):378-83. doi: 10.1136/gut.48.3.378.
3
Familial dysalbuminemic hyperthyroxinemia and thyroid hormone autoantibodies: interference in current free thyroid hormone assays.家族性异常白蛋白血症性高甲状腺素血症与甲状腺激素自身抗体：对当前游离甲状腺激素检测的干扰
Horm Res. 1996;45(3-5):139-41. doi: 10.1159/000184776.
4
Prevalence of thyroid hormone autoantibodies in healthy subjects.健康受试者中甲状腺激素自身抗体的患病率。
Clin Endocrinol (Oxf). 1994 Sep;41(3):365-70. doi: 10.1111/j.1365-2265.1994.tb02558.x.
5
Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia.慢性粒细胞白血病患者接受干扰素α治疗期间的免疫介导及罕见并发症
J Clin Oncol. 1995 Sep;13(9):2401-7. doi: 10.1200/JCO.1995.13.9.2401.
6
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha.重组干扰素α长期治疗期间的甲状腺自身免疫和甲状腺功能减退
Clin Exp Immunol. 1992 Dec;90(3):363-7. doi: 10.1111/j.1365-2249.1992.tb05852.x.
Zotero 插件